Loring Wolcott & Coolidge Fiduciary Advisors LLP Eli Lilly & CO Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$10.5 Billion
Q2 2024

A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 7,421 shares of LLY stock, worth $5.97 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,421

Previous 7,257 2.26%

Holding current value

$5.97 Million

Previous $5.65 Million 19.01%

% of portfolio

0.06%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $118,878 - $149,082	164 Added 2.26%	7,421 $6.72 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $233,919 - $312,950	-395 Reduced 5.16%	7,257 $5.65 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $142,851 - $168,403	272 Added 3.69%	7,652 $4.46 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $1.17 Million - $1.62 Million	2,702 Added 57.76%	7,380 $3.96 Million
Q2 2023 Aug 01, 2023	BUY	$350.74 - $468.98 $185,892 - $248,559	530 Added 12.78%	4,678 $2.19 Million

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $46,624 - $54,327	-145 Reduced 3.38%	4,148 $1.42 Million
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $103,768 - $118,254	350 Added 8.88%	4,293 $1.39 Million
Q2 2022 Jul 26, 2022	BUY	$278.73 - $327.27 $25,921 - $30,436	93 Added 2.42%	3,943 $1.28 Million
Q1 2022 Apr 13, 2022	BUY	$234.69 - $291.66 $32,387 - $40,249	138 Added 3.72%	3,850 $1.1 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $10,118 - $12,556	-45 Reduced 1.2%	3,712 $1.03 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $12,631 - $15,544	57 Added 1.54%	3,757 $868,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $9,388 - $12,144	-52 Reduced 1.39%	3,700 $849,000
Q1 2021 Apr 14, 2021	BUY	$164.32 - $212.72 $13,474 - $17,443	82 Added 2.23%	3,752 $701,000
Q2 2020 Jul 30, 2020	SELL	$136.42 - $164.18 $104,361 - $125,597	-765 Reduced 17.25%	3,670 $603,000
Q1 2020 Apr 15, 2020	SELL	$119.05 - $147.35 $28,572 - $35,364	-240 Reduced 5.13%	4,435 $615,000
Q4 2019 Jan 22, 2020	SELL	$106.92 - $132.43 $10,264 - $12,713	-96 Reduced 2.01%	4,675 $614,000
Q3 2019 Nov 05, 2019	SELL	$106.79 - $116.16 $2,029 - $2,207	-19 Reduced 0.4%	4,771 $534,000
Q2 2019 Aug 09, 2019	BUY	$110.79 - $129.32 $27,143 - $31,683	245 Added 5.39%	4,790 $531,000
Q1 2019 Apr 08, 2019	BUY	$111.31 - $131.02 $16,139 - $18,997	145 Added 3.3%	4,545 $590,000
Q4 2017 Feb 08, 2018	SELL	$81.94 - $87.89 $3,769 - $4,042	-46 Reduced 1.03%	4,400 $372,000
Q3 2017 Oct 27, 2017	BUY	$77.07 - $85.54 $3,545 - $3,934	46 Added 1.05%	4,446 $380,000
Q2 2017 Aug 07, 2017	BUY	N/A	4,400	4,400 $0

Others Institutions Holding LLY

# of Institutions

3,771

Shares Held

737M

Call Options Held

7.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $765B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account

Loring Wolcott & Coolidge Fiduciary Advisors LLP Eli Lilly & CO Transaction History